Pharmaceutical & Therapeutics Committee
The Texas Pharmaceutical and Therapeutics Committee (P&T) is established for the purpose of developing recommendations for preferred drugs lists adopted by the Health and Human Services Commission (HHSC). In developing those recommendations the committee shall consider the clinical efficacy, safety, cost-effectiveness and any program benefit associated with a drug product. The Committee was mandated by House Bill 2292, 78th Legislature, Regular Session, 2003.
About the P & T Committee
Texas Government Code, Section 531.074 requires the appointment of committee members by the Governor. The committee consists of six physicians and five pharmacists actively participating in the Medicaid program.
The Pharmaceutical and Therapeutics Committee meeting schedule for 2013 is:
Testifying at Meetings
Members of the public who wish to testify must register at the meeting site from 8:00am – 9:00am on the morning of the meeting. Each speaker must identify on the registration form the therapeutic drug class and the specific drug(s) on which they will be giving testimony.
Registration to testify will also include the name of the person wishing to testify, address and the organization represented. Registrants are required to disclose on the registration form and in their opening testimony if they are speaking on behalf of any organization or pharmaceutical manufacturer.
Each pharmaceutical manufacturer will be limited to one speaker for each drug product under review. Testimony may be time limited at the direction of the Chairperson and also may be limited to restrict redundant or repetitive testimony.
Written materials relating to drug classes scheduled for review may be submitted for consideration. Materials in excess of 2 pages in length should be submitted by mail only and should consist of 12 copies for distribution to Committee members. Please provide all necessary written materials at least three weeks prior to the next Committee meeting date. Address correspondence to:
Health and Human Services Commission
Vendor Drug Program/Drug Use Review MC-H630
1100 West 49th Street
Austin, TX 78756
- Mario R. Anzaldua, M.D., Mission, TX
- Oralia V. Bazaldua, Pharm.D., San Antonio, TX
- Donna Burkett, M.S., R.Ph., (Vice Chair), Austin, TX
- Rene Garza, Pharm. D., Austin, TX
- Harris Hauser, M.D., (Chairman), Houston, TX
- Daniel R. Hernandez, R.Ph, Harlingen TX
- Melbert “Bob” Hillert, M.D., Dallas, TX
- Scott T. Schams M.D., College Station, TX
- Carl D. Tapia, M.D., Houston, TX